Company intelligence / Profile preview

Golden Vine International

Taiwan

Ownership: Private
Development stage: Other

Overview

Golden Vine International is a healthcare services company focused on expanding access to affordable, advanced medical imaging in Taiwan and Singapore through its exclusive partnership with Nanox, an Israeli medical imaging technology company. The partnership aims to deploy 500 Nanox.ARC and Nanox.CLOUD systems to provide a range of imaging services from 2D X-ray to 3D tomosynthesis computed tomography, operating on a pay-per-scan model. The goal is to enhance early detection and preventive healthcare, particularly in response to the needs of aging populations and during public health crises such as COVID-19

Therapeutic areas: OncologyOther
Modalities: Device
Industry: Non-Academic Healthcare

Partnerships

Nanox

Beyond the preview

Go deeper on Golden Vine International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golden Vine International.

Explore the full profile